A phase 2 trial of sibeprenlimab in patients with IgA nephropathy

…, B Chacko, TM Chan, L Kooienga, KH Oh… - … England Journal of …, 2024 - Mass Medical Soc
Background A proliferation-inducing ligand (APRIL) is implicated in the pathogenesis of IgA
nephropathy. Sibeprenlimab is a humanized IgG2 monoclonal antibody that binds to and …

Association of depression with malnutrition in chronic hemodialysis patients

JR Koo, JW Yoon, SG Kim, YK Lee, KH Oh… - American journal of …, 2003 - Elsevier
BACKGROUND:: Depression is the most common psychological complication and may
increase mortality in chronic hemodialysis patients. Because depression could be associated …

[HTML][HTML] The KNOW-CKD Study: What we have learned about chronic kidney diseases

KH Oh, M Kang, E Kang, H Ryu, SH Han… - Kidney Research and …, 2020 - ncbi.nlm.nih.gov
Kook-Hwan Oh revised and edited the manuscript. Kook-Hwan Oh, Seung Hyeok Han,
Tae-Hyun Yoo, Soo Wan Kim, Sue K. Park, Kyu-… Curie Ahn and Kook-Hwan Oh funded the study. …

[HTML][HTML] KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods

KH Oh, SK Park, HC Park, HJ Chin, DW Chae, KH Choi… - BMC nephrology, 2014 - Springer
Background The progression and complications of chronic kidney disease should differ
depending on the cause (C), glomerular filtration rate category (G), and albuminuria (A). The …

Safety and efficacy of immune checkpoint inhibitors for end-stage renal disease patients undergoing dialysis: a retrospective case series and literature review

H Cheun, M Kim, H Lee, KH Oh, B Keam - Investigational New Drugs, 2019 - Springer
Despite the lack of safety and efficacy data regarding immune checkpoint inhibitors (ICIs) for
renal dysfunction, they have been approved to treat even in the patients with end-stage …

[HTML][HTML] Environmental heavy metal exposure and chronic kidney disease in the general population

…, KB Lee, Y Chang, S Rhu, KH Oh… - Journal of Korean …, 2015 - ncbi.nlm.nih.gov
Lead (Pb), mercury (Hg), and cadmium (Cd) are common heavy metal toxins and cause
toxicological renal effects at high levels, but the relevance of low-level environmental exposures …

Obesity, metabolic abnormality, and progression of CKD

…, KH Choi, S Sung, SW Kim, J Lee, KH Oh… - American Journal of …, 2018 - Elsevier
Rationale & Objective Recent studies have yielded conflicting findings on the association
between obesity and progression of chronic kidney disease (CKD). Few studies have …

Left Ventricular Diastolic Dysfunction and Progression of Chronic Kidney Disease: Analysis of KNOW‐CKD Data

…, JY Jung, KB Lee, SH Han, C Ahn, KH Oh - Journal of the …, 2022 - Am Heart Assoc
Background Few studies have examined the association between the early diastolic mitral
inflow velocity/early diastolic mitral annulus velocity ratio (E/e’) and chronic kidney disease …

[HTML][HTML] Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study

TR Oh, HS Choi, CS Kim, EH Bae, SK Ma, SA Sung… - Scientific reports, 2019 - nature.com
The prevalence of hyperuricemia and chronic kidney disease (CKD) has been steadily
increasing. The role of hyperuricemia and efficacy of uric acid-lowering agents against CKD …

Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report

SM Kim, R Cha, JP Lee, DK Kim, KH Oh, KW Joo… - American Journal of …, 2010 - Elsevier
BACKGROUND: Although there has been considerable investigation of the general
characteristics of contrast-induced nephropathy (CIN), it has not been studied adequately in a …